Modeling of skeletal development and diseases using human pluripotent stem cells

被引:0
|
作者
Hojo, Hironori [1 ,2 ]
Tani, Shoichiro [3 ]
Ohba, Shinsuke [4 ]
机构
[1] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Div Clin Biotechnol, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138655, Japan
[3] Univ Texas Southwestern Med Ctr, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA
[4] Osaka Univ, Grad Sch Dent, Dept Tissue & Dev Biol, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
human pluripotent stem cells; skeletal development; disease modeling; osteoblasts; chondrocytes; ON-A-CHIP; HUMAN SEGMENTATION CLOCK; NEURAL CREST CELLS; OSTEOBLAST DIFFERENTIATION; BONE REGENERATION; SHH ESTABLISHES; AXIAL SKELETON; FEEDBACK LOOP; MESODERM; BMP;
D O I
10.1093/jbmr/zjae178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human skeletal elements are formed from distinct origins at distinct positions of the embryo. For example, the neural crest produces the facial bones, the paraxial mesoderm produces the axial skeleton, and the lateral plate mesoderm produces the appendicular skeleton. During skeletal development, different combinations of signaling pathways are coordinated from distinct origins during the sequential developmental stages. Models for human skeletal development have been established using human pluripotent stem cells (hPSCs) and by exploiting our understanding of skeletal development. Stepwise protocols for generating skeletal cells from different origins have been designed to mimic developmental trails. Recently, organoid methods have allowed the multicellular organization of skeletal cell types to recapitulate complicated skeletal development and metabolism. Similarly, several genetic diseases of the skeleton have been modeled using patient-derived induced pluripotent stem cells and genome-editing technologies. Model-based drug screening is a powerful tool for identifying drug candidates. This review briefly summarizes our current understanding of the embryonic development of skeletal tissues and introduces the current state-of-the-art hPSC methods for recapitulating skeletal development, metabolism, and diseases. We also discuss the current limitations and future perspectives for applications of the hPSC-based modeling system in precision medicine in this research field. Human bones have different origins in the embryo: facial bones originate from the neural crest, axial skeleton from the paraxial mesoderm, and limb bones from the lateral plate mesoderm. Human stem cells have been used to model bone development by mimicking the developmental processes. Recent advancements, such as organoid methods, have helped recreate complex bone development. Genetic bone diseases have also been studied using stem cells and gene editing technology. These models hold promise for improving precision medicine. This review overviews our understanding of bone development, introduces current advancements, and provides future perspectives for bone and stem cell research.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Modeling human skeletal development using human pluripotent stem cells
    Lamande, Shireen R.
    Ng, Elizabeth S.
    Cameron, Trevor L.
    Kung, Louise H. W.
    Sampurno, Lisa
    Rowley, Lynn
    Lilianty, Jinia
    Patria, Yudha Nur
    Stenta, Tayla
    Hanssen, Eric
    Bell, Katrina M.
    Saxena, Ritika
    Stok, Kathryn S.
    Stanley, Edouard G.
    Elefanty, Andrew G.
    Bateman, John F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (19)
  • [2] Pancreatic Diseases: Genetics and Modeling Using Human Pluripotent Stem Cells
    Lee, Yuri
    Lee, Kihyun
    INTERNATIONAL JOURNAL OF STEM CELLS, 2024, 17 (03) : 253 - 269
  • [3] Modeling placental development and disease using human pluripotent stem cells
    Morey, Robert
    Bui, Tony
    Fisch, Kathleen M.
    Horii, Mariko
    PLACENTA, 2023, 141 : 18 - 25
  • [4] Modeling human lung development and disease using pluripotent stem cells
    Snoeck, Hans-Willem
    DEVELOPMENT, 2015, 142 (01): : 13 - 16
  • [5] Stem Cells on the Brain: Modeling Neurodevelopmental and Neurodegenerative Diseases Using Human Induced Pluripotent Stem Cells
    Srikanth, Priya
    Young-Pearse, Tracy L.
    JOURNAL OF NEUROGENETICS, 2014, 28 (1-2) : 5 - 29
  • [6] Modeling blood diseases with human induced pluripotent stem cells
    Georgomanoli, Maria
    Papapetrou, Eirini P.
    DISEASE MODELS & MECHANISMS, 2019, 12 (06)
  • [7] MODELING HUMAN HEMATOPOIETIC DEVELOPMENT WITH PLURIPOTENT STEM CELLS
    Keller, Gordon
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S38 - S38
  • [8] In vitro modeling of dysfunctional glial cells in neurodegenerative diseases using human pluripotent stem cells
    Garcia Leon, J. A.
    Eggermont, K.
    Neyrinck, K.
    Davila, J. C.
    Vitorica, J.
    Verfaillie, C.
    Gutierrez, A.
    GLIA, 2019, 67 : E164 - E165
  • [9] Modeling aortic diseases using induced pluripotent stem cells
    Zhu, Kai
    Ma, Wenrui
    Li, Jun
    Zhang, Yu Shrike
    Zhang, Weijia
    Lai, Hao
    Wang, Chunsheng
    STEM CELLS TRANSLATIONAL MEDICINE, 2021, 10 (02) : 190 - 197
  • [10] In Vitro Modeling of Human Germ Cell Development Using Pluripotent Stem Cells
    Zhao, Yuncheng
    Ye, Shicheng
    Liang, Dongli
    Wang, Pengxiang
    Fu, Jing
    Ma, Qing
    Kong, Ruijiao
    Shi, Linghong
    Gong, Xueping
    Chen, Wei
    Ding, Wubin
    Yang, Wenjing
    Zhu, Zijue
    Chen, Huixing
    Sun, Xiaoxi
    Zhu, Jun
    Li, Zheng
    Wang, Yuan
    STEM CELL REPORTS, 2018, 10 (02): : 509 - 523